Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42, R43/R44 Clinical Trial Optional)

Funding Agency:
National Institutes of Health
The purpose of this Funding Opportunity Announcement is to support research applications for commercializable, digital products that aim at positively affecting the fundamental social and environmental conditions that are risk factors for the populations affected by substance use/misuse or Substance Use Disorders (excluding Alcohol Use Disorder).
Companion FOA: RFA-DA-21-031 - Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) 


  • Letters of Intent Receipt Date(s): 30 days prior to the application due date
  • Application Due Date(s): February 26, 2021

RFA-DA-21-032 Expiration Date: February 27, 2021

Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

February 27, 2021